• Latest Posts

Seven pharma companies form alliance to prepare for future pandemics 

Shasqi using click chemistry to target cancer

In Depth 17 Jan 2023

Cell and gene therapies gain momentum in Basel

LIfT BioSciences gets a double boost

ASPIRE set up to collaborate on amyloidosis

Hope for children with chronic graft versus host disease as Johnson & Johnson drug approved


Yumanity selling neurology assets and merging with Kineta

As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

Which European Blockbusters Topped the Charts in 2016?

Actelion’s key Drug linked to Deaths, prompting EMA Investigation